Hyperactivation of the hypothalamic–pituitary–adrenal (HPA) axis and continuous increase in glucocorticoid levels in patients with depression inhibited the immune response and increased the serum levels of proinflammatory cytokines IL-6 and IL-2 (Ding and Dai, 2019). Here, IL2 is linked to depressive symptom measurement.